Oxford Vacmedix Company
Develop therapeutic agents for the treatment of cancer .
Funding Status:
Early Stage Venture
Total Funding:
12500000
Last Funding Type:
Series A
Industry:
Peptides and Proteins
Estimated Revenue:
$1M to $10M
Founded Date:
2012-01-01
Last Funding Date:
2018-03-06
Headquarters:
Oxford, Oxfordshire, United Kingdom
Employee Number:
1-10
Investors Number:
2

